Literature DB >> 12827459

The proteins of the Hepatitis C virus: their features and interactions with intracellular protein phosphorylation.

J Schulze zur Wiesch1, H Schmitz, E Borowski, P Borowski.   

Abstract

Chronic infection with Hepatitis C virus (HCV) often results in cirrhosis and enhances the probability of developing hepatocellular carcinoma (HCC). The underlying mechanisms that lead to malignant transformation of infected cells, however, remain unclear. Observations made with isolated HCV antigens and/or with HCV subgenomic replicon systems demonstrated that the products encoded in the HCV genome interfere with and disturb intracellular signal transduction, often by phosphorylation of cellular proteins. Moreover, some of the HCV-encoded proteins seem to serve as substrates for host cell protein kinases. These phosphorylations affect the biological functions of the antigens. In many cases it could be demonstrated that only short stretches of the linear sequence of the viral or cellular proteins are involved and play a crucial role for these phosphorylation events. The identification of these small polypeptide elements and the subsequent development of strategies to inhibit protein-protein interactions involving them may be the first step towards reducing the chronicity and/or of the carcinogenicity of the virus. This review summarizes current knowledge of intracellular phosphorylation processes that are affected by HCV.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12827459     DOI: 10.1007/s00705-003-0115-8

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  9 in total

1.  Uncoupling substrate and activation functions of rotavirus NSP5: phosphorylation of Ser-67 by casein kinase 1 is essential for hyperphosphorylation.

Authors:  Catherine Eichwald; Germaine Jacob; Bartosz Muszynski; Jorge E Allende; Oscar R Burrone
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-01       Impact factor: 11.205

Review 2.  Viral infection and human disease--insights from minimotifs.

Authors:  Krishna Kadaveru; Jay Vyas; Martin R Schiller
Journal:  Front Biosci       Date:  2008-05-01

Review 3.  Progress in the development of vaccines for hepatitis C virus infection.

Authors:  Faezeh Ghasemi; Sina Rostami; Zahra Meshkat
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

4.  Liver angiogenesis as a risk factor for hepatocellular carcinoma development in hepatitis C virus cirrhotic patients.

Authors:  Roberto Mazzanti; Luca Messerini; Camilla E Comin; Lorenzo Fedeli; Nathalie Ganne-Carrie; Michel Beaugrand
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

Review 5.  Similarities and differences in hepatitis B and C virus induced hepatocarcinogenesis.

Authors:  Erzsébet Szabó; Csilla Páska; Pál Kaposi Novák; Zsuzsa Schaff; András Kiss
Journal:  Pathol Oncol Res       Date:  2004-03-18       Impact factor: 3.201

Review 6.  Recombination in hepatitis C virus.

Authors:  Fernando González-Candelas; F Xavier López-Labrador; María Alma Bracho
Journal:  Viruses       Date:  2011-10-24       Impact factor: 5.048

7.  Evidence of recombination in intrapatient populations of hepatitis C virus.

Authors:  Vicente Sentandreu; Nuria Jiménez-Hernández; Manuela Torres-Puente; María Alma Bracho; Ana Valero; María José Gosalbes; Enrique Ortega; Andrés Moya; Fernando González-Candelas
Journal:  PLoS One       Date:  2008-09-18       Impact factor: 3.240

8.  Evaluation of cellular responses for a chimeric HBsAg-HCV core DNA vaccine in BALB/c mice.

Authors:  Maryam Yazdanian; Arash Memarnejadian; Mehdi Mahdavi; Fatemeh Motevalli; Seyed Mehdi Sadat; Rouhollah Vahabpour; Hossein Khanahmad; Hoorieh Soleimanjahi; Agata Budkowska; Farzin Roohvand
Journal:  Adv Biomed Res       Date:  2015-01-06

9.  Transcriptional analysis of avian embryonic tissues following infection with avian infectious bronchitis virus.

Authors:  Arshud Dar; Shirin Munir; Satya Vishwanathan; Anju Manuja; Philip Griebel; Suresh Tikoo; Hugh Townsend; Andrew Potter; Vivek Kapur; Lorne A Babiuk
Journal:  Virus Res       Date:  2005-06       Impact factor: 3.303

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.